Trial of tDCS as Early Augmentation in Adults with Depressio
Phase 4
- Conditions
- Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresHealth Condition 2: F331- Major depressive disorder, recurrent, moderateHealth Condition 3: F321- Major depressive disorder, singleepisode, moderateHealth Condition 4: F322- Major depressive disorder, singleepisode, severe without psychotic features
- Registration Number
- CTRI/2022/01/039123
- Lead Sponsor
- King Georges Medical University Lucknow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age 18-60 years
2. Patients diagnosed with Major Depressive Disorder according to DSM-5
3. Willing to give Informed consent to participate in the study.
4. Drug Naive (at least drug free for the past 1 month)
Exclusion Criteria
1. Patients with Treatment Resistant Depression.
2. Patients having Psychotic Depression.
Suicidal Patients
3. HAM-D (Hamilton Depression Rating Scale) less than 13
4. Medical co-morbidities that need immediate attention.
5. Any contraindications to tDCS.
6. Patients with any other co-morbid psychiatric disorder except Tobacco use disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study efficacy of transcranial direct current stimulation in Major Depressive DisorderTimepoint: Assessment at 0, 2 and 4 weeks
- Secondary Outcome Measures
Name Time Method To study safety of transcranial direct current stimulation in Major Depressive DisorderTimepoint: Assessment at each session